GlaxoSmithKline | GSK - Operating Expenses

Stock Price
2,080.00
Daily Change
134.50 6.91%
Monthly
14.25%
Yearly
40.07%
Q1 Forecast
1,839.16

GlaxoSmithKline reported GBP5.76B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AbbVie USD -2.64B 12.35B Sep/2025
Alcon AG USD 2.28B 67M Sep/2025
Almirall EUR 517.43M 43.18M Jun/2025
Amgen USD 5.9B 773M Dec/2025
argenx SE USD 776.99M 32.87M Sep/2025
AstraZeneca USD 16.69B 5.74B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
Bristol-Myers Squibb USD 18.55B 10.06B Sep/2025
Eli Lilly USD 9.21B 677.8M Sep/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.43B 73.91M Sep/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
Gilead Sciences USD 4.26B 95M Sep/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
Glaxosmithkline GBP 7.77B 2.22B Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Merck USD 10.16B 558M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Novo Nordisk DKK 46.76B 3.99B Dec/2025
Orion EUR 302.2M 9.7M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Philips EUR 3.97B 123M Sep/2025
Recordati EUR 466.68M 27.25M Sep/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
UCB EUR 2.36B 108M Dec/2024